Intake questionnaire
Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA)
Applying to Dana-Farber Cancer Institute · Boston, Massachusetts
Answer a few short questions to share with the research team.
0 of 4 answered
Intake questionnaire
Applying to Dana-Farber Cancer Institute · Boston, Massachusetts
Answer a few short questions to share with the research team.
0 of 4 answered